Olga Afanasiev, MD
Dermatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Afanasiev’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A144290 · Current
Licensed to practise in California · since 2016 · expires 2028-05-31 · University of Washington School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$99,892
Medicare paid this office $99,892 for 385 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 175 | $25,439 | $108 |
| Short return visit (20+ min) | 193 | $17,112 | $73 |
| Destruction of precancer skin growth, 1 growth | 156 | $10,402 | $50 |
| Destruction of skin growth, 1-14 growths | 69 | $8,639 | $107 |
| Biopsy of related skin growth, first growth | 78 | $8,604 | $87 |
See all 14 services
| Return visit (30+ min) | 175 | $25,439 | $108 |
| Short return visit (20+ min) | 193 | $17,112 | $73 |
| Destruction of precancer skin growth, 1 growth | 156 | $10,402 | $50 |
| Destruction of skin growth, 1-14 growths | 69 | $8,639 | $107 |
| Biopsy of related skin growth, first growth | 78 | $8,604 | $87 |
| Destruction of precancer skin growth, 15 or more growths | 27 | $6,632 | $170 |
| Destruction of precancer skin growth, 2-14 growths | 119 | $4,058 | $7 |
| New patient visit (45+ min) | 19 | $2,369 | $125 |
| Punch biopsy, first skin growth | 13 | $1,711 | $132 |
| New patient visit (30+ min) | 18 | $1,552 | $86 |
| Short return visit | 29 | $1,462 | $47 |
| Application of ultraviolet light to skin | 22 | $1,349 | $28 |
| Biopsy of related skin growth, each additional growth | 20 | $1,280 | $49 |
| Biopsy of ear | 11 | $886 | $81 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 639 | More than 89% of doctors who do this |
| Removal or shaving of skin growth | 16 | More than 69% of doctors who do this |
| Skin biopsy | 208 | More than 85% of doctors who do this |
Who their Medicare patients are
385 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 15% · Women 51% · Also on Medicaid 8% · Health risk score 0.96. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 60% · Coronary heart disease 22% · Chronic kidney disease 21% · Diabetes 18% · Cancer 18% · Atrial fibrillation 15% · Depression 12% · Heart failure 7% · COPD 5% · Dementia 4% · Stroke 4%.
The office billed $367,667, Medicare allowed $141,042 and paid $99,892; for 1,722 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 385 | 1,722 | 76 | 0.96 | $367,667 | $99,892 |
| 2023 | 392 | 1,962 | 76 | 0.88 | $444,976 | $127,217 |
| 2022 | 274 | 1,464 | 76 | 0.95 | $287,736 | $90,791 |
| 2021 | 255 | 1,152 | 76 | 0.97 | $240,870 | $70,506 |
| 2020 | 235 | 995 | 76 | 0.93 | $227,996 | $62,901 |
| 2019 | 74 | 201 | 74 | 0.89 | $46,736 | $13,151 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Return visit (30+ min) | 173 | $30,912 | $108 |
| Short return visit (20+ min) | 171 | $16,735 | $76 |
| Destruction of precancer skin growth, 1 growth | 146 | $12,492 | $56 |
| Biopsy of related skin growth, first growth | 84 | $10,240 | $94 |
| Destruction of skin growth, 1-14 growths | 70 | $9,119 | $109 |
| Destruction of precancer skin growth, 15 or more growths | 24 | $6,833 | $175 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 20 | $6,413 | $321 |
| Destruction of precancer skin growth, 2-14 growths | 112 | $4,263 | $7 |
| New patient visit (45+ min) | 27 | $3,628 | $134 |
| Application of ultraviolet light to skin | 26 | $3,371 | $27 |
| New patient visit (30+ min) | 29 | $2,422 | $84 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 17 | $2,187 | $115 |
| Punch biopsy, first skin growth | 15 | $2,045 | $128 |
| Biopsy of related skin growth, each additional growth | 23 | $1,875 | $54 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $1,787 | $128 |
| Short return visit | 31 | $1,585 | $51 |
| New patient visit (15+ min) | 11 | $651 | $59 |
2022: 13 services
| Return visit (30+ min) | 125 | $20,716 | $118 |
| Short return visit (20+ min) | 120 | $11,551 | $80 |
| Biopsy of related skin growth, first growth | 83 | $10,858 | $100 |
| Destruction of precancer skin growth, 1 growth | 120 | $8,193 | $51 |
| Destruction of skin growth, 1-14 growths | 52 | $7,615 | $117 |
| Destruction of precancer skin growth, 15 or more growths | 21 | $5,663 | $177 |
| Destruction of precancer skin growth, 2-14 growths | 94 | $3,533 | $7 |
| Biopsy of related skin growth, each additional growth | 27 | $2,705 | $54 |
| New patient visit (45+ min) | 18 | $2,619 | $146 |
| Application of ultraviolet light to skin | 18 | $2,443 | $27 |
| Punch biopsy, first skin growth | 15 | $1,876 | $125 |
| New patient visit (30+ min) | 18 | $1,627 | $90 |
| Short return visit | 23 | $1,140 | $50 |
2021: 12 services
| Short return visit (20+ min) | 134 | $12,609 | $76 |
| Return visit (30+ min) | 83 | $12,267 | $107 |
| Biopsy of related skin growth, first growth | 82 | $9,427 | $100 |
| Destruction of precancer skin growth, 1 growth | 82 | $5,492 | $47 |
| Destruction of skin growth, 1-14 growths | 32 | $4,152 | $115 |
| Punch biopsy, first skin growth | 22 | $3,072 | $123 |
| New patient visit (30+ min) | 30 | $2,928 | $98 |
| Destruction of precancer skin growth, 2-14 growths | 64 | $2,282 | $7 |
| Application of ultraviolet light to skin | 12 | $2,052 | $25 |
| Biopsy of related skin growth, each additional growth | 26 | $1,783 | $56 |
| Short return visit | 34 | $1,527 | $41 |
| New patient visit (45+ min) | 11 | $1,037 | $94 |
2020: 13 services
| Return visit (30+ min) | 100 | $11,725 | $92 |
| Biopsy of related skin growth, first growth | 87 | $10,063 | $98 |
| Short return visit (20+ min) | 88 | $7,117 | $67 |
| Destruction of precancer skin growth, 1 growth | 90 | $4,994 | $43 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $4,655 | $310 |
| Destruction of skin growth, 1-14 growths | 26 | $3,025 | $101 |
| Biopsy of related skin growth, each additional growth | 35 | $2,593 | $55 |
| New patient visit (30+ min) | 28 | $2,055 | $73 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $2,014 | $126 |
| Destruction of precancer skin growth, 2-14 growths | 66 | $1,513 | $6 |
| New patient visit (15+ min) | 26 | $1,308 | $50 |
| Application of ultraviolet light to skin | 12 | $927 | $24 |
| Short return visit | 15 | $769 | $45 |
2019: 6 services
| Short return visit (20+ min) | 32 | $2,401 | $71 |
| Biopsy of related skin growth, first growth | 25 | $2,397 | $96 |
| Return visit (30+ min) | 19 | $2,074 | $99 |
| New patient visit (30+ min) | 19 | $1,679 | $88 |
| Destruction of precancer skin growth, 1 growth | 19 | $863 | $45 |
| Destruction of precancer skin growth, 2-14 growths | 14 | $216 | $6 |
Drugs they prescribed that Part D paid
$119,452
Pharmacies billed $119,452 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 526) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
499 generic and 27 brand-name prescriptions · $119,452 in drug cost · 20 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluorouracil | 69 | $5,485 | $79 |
| Clobetasol Propionate | 51 | $2,296 | $45 |
| Calcipotriene | 11 | $1,955 | $178 |
| Ketoconazole | 79 | $1,186 | $15 |
| Fluocinonide | 27 | $1,078 | $40 |
See all 13 drugs
| Fluorouracil | 69 | $5,485 | $79 |
| Clobetasol Propionate | 51 | $2,296 | $45 |
| Calcipotriene | 11 | $1,955 | $178 |
| Ketoconazole | 79 | $1,186 | $15 |
| Fluocinonide | 27 | $1,078 | $40 |
| Triamcinolone Acetonide | 59 | $993 | $17 |
| Metronidazole | 12 | $805 | $67 |
| Clindamycin Phosphate | 24 | $599 | $25 |
| Ciclopirox | 15 | $435 | $29 |
| Hydrocortisone | 32 | $422 | $13 |
| Doxycycline Monohydrate | 17 | $389 | $23 |
| Mupirocin | 53 | $358 | $7 |
| Econazole Nitrate | 12 | $340 | $28 |
Year by year
| 2024 | 526 | 201 | 0% (0) | 5% | $119,452 |
| 2023 | 518 | 209 | 0% (0) | 7% | $160,755 |
| 2022 | 371 | 146 | 0% (0) | 12% | $27,260 |
| 2021 | 307 | 127 | 0% (0) | None | $18,375 |
| 2020 | 280 | 106 | 0% (0) | 14% | $18,986 |
| 2019 | 59 | 26 | 0% (0) | None | $65,523 |
| 2016 | 29 | 14 | None | None | $840 |
| 2015 | 30 | None | None | None | $958 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Fluorouracil | 73 | $5,796 | $79 |
| Clobetasol Propionate | 46 | $3,060 | $67 |
| Fluocinonide | 32 | $1,589 | $50 |
| Ketoconazole | 69 | $1,489 | $22 |
| Triamcinolone Acetonide | 69 | $1,342 | $19 |
| Clindamycin Phosphate | 16 | $631 | $39 |
| Mupirocin | 57 | $604 | $11 |
| Econazole Nitrate | 15 | $459 | $31 |
| Hydrocortisone | 46 | $260 | $6 |
| Doxycycline Hyclate | 11 | $204 | $19 |
2022: 11 drugs
| Fluorouracil | 57 | $5,402 | $95 |
| Calcipotriene | 29 | $4,955 | $171 |
| Clobetasol Propionate | 38 | $3,444 | $91 |
| Betamethasone Dipropionate | 11 | $977 | $89 |
| Triamcinolone Acetonide | 59 | $809 | $14 |
| Clindamycin Phosphate | 13 | $719 | $55 |
| Ketoconazole | 27 | $635 | $24 |
| Metronidazole | 12 | $626 | $52 |
| Fluocinonide | 12 | $610 | $51 |
| Mupirocin | 40 | $461 | $12 |
| Hydrocortisone | 21 | $128 | $6 |
2021: 10 drugs
| Calcipotriene | 19 | $3,420 | $180 |
| Fluorouracil | 28 | $2,498 | $89 |
| Clobetasol Propionate | 23 | $2,493 | $108 |
| Tacrolimus | 12 | $1,950 | $162 |
| Triamcinolone Acetonide | 61 | $1,275 | $21 |
| Fluocinonide | 18 | $1,111 | $62 |
| Ketoconazole | 36 | $872 | $24 |
| Metronidazole | 11 | $783 | $71 |
| Hydrocortisone | 19 | $338 | $18 |
| Mupirocin | 27 | $264 | $10 |
2020: 8 drugs
| Fluorouracil | 48 | $5,787 | $121 |
| Calcipotriene | 21 | $5,107 | $243 |
| Fluocinonide | 22 | $1,506 | $68 |
| Triamcinolone Acetonide | 43 | $927 | $22 |
| Ketoconazole | 30 | $763 | $25 |
| Doxycycline Hyclate | 18 | $753 | $42 |
| Mupirocin | 19 | $231 | $12 |
| Hydrocortisone | 19 | $146 | $8 |
Money from drug and device companies
$2,066 in 2025
| 2025 | 12 | 18 | $1,660 | $2,066 |
| 2024 | 6 | 10 | $2,490 | $2,772 |
| 2023 | 1 | 2 | $4,985 | $4,985 |
| 2022 | 2 | 2 | $1,040 | $1,065 |
| 2019 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | None | $1,660 | 1 payment
|
| Janssen Biotech | Tremfya | $96 | 5 payments
|
| Galderma Laboratories L.P. | Nemluvio | $68 | 3 payments
|
| Genzyme | Dupixent | $42 | 1 payment
|
| Incyte | Opzelura | $31 | 1 payment
|
| Revance Therapeutics | Daxi | $30 | 1 payment
|
See all 18 published payments
| Janssen Biotech | Meals · 2025-12-15 | Tremfya | $18 |
| Pfizer | Meals · 2025-12-03 | Cibinqo | $26 |
| Janssen Biotech | Meals · 2025-11-17 | Tremfya | $14 |
| Gilead Sciences | Consulting · 2025-11-12 | None | $1,660 |
| Regeneron Healthcare Solutions | Meals · 2025-10-30 | Dupixent | $24 |
| Galderma Laboratories L.P. | Meals · 2025-10-27 | Nemluvio | $26 |
| Janssen Biotech | Meals · 2025-08-04 | Tremfya | $23 |
| Galderma Laboratories L.P. | Meals · 2025-08-04 | Nemluvio | $23 |
| Revance Therapeutics | Meals · 2025-07-22 | Daxi | $30 |
| Abbvie | Meals · 2025-07-01 | Skyrizi | $17 |
| Galderma Laboratories L.P. | Meals · 2025-05-19 | Nemluvio | $19 |
| Janssen Biotech | Meals · 2025-05-02 | Tremfya | $20 |
| Amgen | Meals · 2025-04-30 | Otezla | $25 |
| Incyte | Meals · 2025-04-22 | Opzelura | $31 |
| STRATA Skin Sciences | Meals · 2025-02-17 | Xtrac | $26 |
| Janssen Biotech | Meals · 2025-02-05 | Tremfya | $21 |
| Genzyme | Meals · 2025-02-03 | Dupixent | $42 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-13 | Sotyktu | $22 |
See earlier years (2024, 2023, 2022, 2019)
2024: $2,772
| Gilead Sciences | Biktarvy | $2,490 | 1 payment
|
| Genzyme | Dupixent | $123 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $100 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $27 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $18 | 1 payment
|
| Almirall | Klisyri | $13 | 1 payment
|
2023: $4,985
| Gilead Sciences | None | $4,985 | 2 payments
|
2022: $1,065
| Gilead Sciences | None | $1,040 | 1 payment
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $25 | 1 payment
|
2019: $125
| Regeneron Healthcare Solutions | Dupixent | $125 | 1 payment
|
Professional record
- NPI
- 1669869384
- Licence
- CA A144290California A144290: Current · expires 2028-05-31
- Trained
- University of Washington School of Medicine, 2015
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2015-04-21
- NPI last updated
- 2019-09-25
This is when the NPI record was last certified, not a medical board exam.